Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.40 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.40 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26093006 | 0.76 | CA2 (0.44) | TSHRCA2 | |
| SCHEMBL4303373 | 0.76 | CA2 (0.44) | TSHRCA2 | |
| SCHEMBL7447345 | 0.73 | TSHR (0.35) | TSHRTP53EGLN1EGLN3HCAR2 | |
| SCHEMBL7447664 | 0.73 | TSHR (0.35) | TSHRTP53EGLN1EGLN3HCAR2 | |
| SCHEMBL15717692 | 0.70 | — | — | |
| Maleic Acid SCHEMBL11860272 | 0.70 | TSHR (0.69) | TSHRTP53EGLN1EGLN3HCAR2 | |
| Fumaric Acid SCHEMBL6095324 | 0.70 | TSHR (0.69) | TSHRTP53EGLN1EGLN3HCAR2 | |
| Fumaric Acid SCHEMBL6095338 | 0.70 | TSHR (0.69) | TSHRTP53EGLN1EGLN3HCAR2 | |
| Maleic Acid SCHEMBL27382798 | 0.69 | TSHR (0.56) | TSHRTP53EGLN1EGLN3HCAR2 | |
| Maleic Acid SCHEMBL11768683 | 0.67 | TSHR (0.64) | TSHRTP53EGLN1EGLN3HCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8742013-B2 | Synthesis of lipoamide-grafted high molecular compound and method therefor | Seoul National University of Technology Center for Industrial Collaboration (KR) | 2014-06-03 | — | — | US | disclosed |
| EP-2251359-A1 | Synthesis of Lipoamide-Grafted High Molecular Compound and Method Therefor | Seoul National University of Technology Center for Industry Collaboration (KR) | 2010-11-17 | — | — | EP | disclosed |
| US-20100272761-A1 | SYNTHESIS OF LIPOAMIDE-GRAFTED HIGH MOLECULAR COMPOUND AND METHOD THEREFOR | Seoul National University of Technology Center for Industrial Collaboration (KR) | 2010-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100272761-A1 | SYNTHESIS OF LIPOAMIDE-GRAFTED HIGH MOLECULAR COMPOUND AND METHOD THEREFOR | HDGF, HASPIN, LIPE | TSHR 2727/4885TP53 1315/4885EGLN1 219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.